Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Role of Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI: A Double Blind Placebo Controlled Study.

NCT02766764 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT02766764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02766764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Role of Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI: A Double Blind Placebo Controlled Study.
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2016
Completion date
Not reported
Enrollment
230 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

subfertility